Sentinel lymph node biopsy in Melanoma of the head and neck

Plastic and Reconstructive Surgery

Volumn 100, Issue 3, 1997, Pages 591-594

  Wells, Karen E ^a,b   Rapaport, David P ^a   Cruse, C Wayne ^a   Payne, Wyatt ^a   Albertini, John ^a   Berman, Claudia ^a   Lyman, Gary H ^a   Reintgen, Douglas S ^a  

^a H Lee Moffitt Cancer Center and Research Institute ^*

^b H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; HEAD AND NECK CANCER; HUMAN; LYMPH NODE BIOPSY; LYMPH NODE METASTASIS; LYMPHADENECTOMY; LYMPHOSCINTIGRAPHY; MALE; MELANOMA; PRIORITY JOURNAL; TREATMENT OUTCOME;

BIOPSY; FEMALE; HEAD; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MELANOMA; MIDDLE AGED; NECK; ROSANILINE DYES; SKIN NEOPLASMS; TECHNETIUM TC 99M SULFUR COLLOID;

EID: 0030866449     PISSN: 00321052     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006534-199709000-00006     Document Type: Article

References (10)

1. Reinigen, D., Cruse, C. W., Wells, K., Berman, C., Fenske, N., Glass, F., Schroer, K., Heller, R., Ross, M., Lyman, G., Cox, C., Rapaport, D., Seigler, H. F., and Balch, C. The orderly progression of melanoma nodal metastases. Ann. Surg. 220: 759, 1994.
2. Albertini, J.J., Cruse, C. W., Rapaport, D., Wells, K., Ross, M., DeConti, R., Berman, C., Jared, K., Messina, J., Lyman, G., Glass, F., Fenske, N., and Reinigen, D. Intraoperative radiolymphoscintigraphy improves sentinel node identification in melanoma patients. Ann. Surg. 223: 217, 1990.
3. Wells, K. E., Cruse, C. W., Daniels, S., Berman, C., Norman, J., and Reinigen, D. S. The use of lymphoscintigraphy in melanoma of the head and neck. Plast. Reconstr. Surg. 93: 757, 1994.
4. O'Brien, C. J, Uren, R. F., Thompson, J. F., Howman-Giles, R. B., Petersen-Schaefer, K., Shaw, H. M., Quinn, M. J., and McCarthy, W. H. Prediction of potential metastatic sites in cutaneous head, and neck melanoma using lymphoscintigraphy. Am. J. Surg. 170: 461, 1995.
5. Berman, C. G., Norman, J., Cruse, C. W., Reinigen, D. S., and Clarks, R. A. Lymphoscintigraphy in malignant melanoma. Ann. Plast. Surg. 28: 29, 1992.
6. G. Norman, J., Cruse, C. W., Espinosa, C., Cox, C., Berman, C., Clark, R., Saba, H., Wells, K., and Reinigen, D. Redefinition of cutaneous lymphatic drainage with the use of lymphoscintigraphy for malignant melanoma. Am. J. Surg. 162: 432, 1991.
7. Reintgen, D. S., Vollmer, R., Tso, C. Y., and Seigler, H. F. Prognosis for recurrent stage I malignant melanoma. Arch. Surg. 122: 1338, 1987.
8. Kirkwood, J. M., Strawderman, M. H., Ernstoff, M. S., Smith, T. J., Borden, E. C., and Blum, R. H. Interferon alpha-2b adjuvant therapy of high-risk resected cutaneous melanoma: The Eastern Cooperative Oncology-Group trial EST 1684. J. Clin. Oncol. 14: 7, 1996.
9. Balch, C. M., and Buzaid, A. C. Finally, a successful adjuvant therapy for high-risk melanoma (Editorial). J. Clin. Oncol. 14: 1, 1996.
10. Balch, C. A. Prospective randomized surgical trial of 742 melanoma patients comparing the efficacy of elective (immediate) lymph node dissection versus observation. In Proceedings of the Annual Meeting of the American Surgical Association, Palm Springs, Calif., April 1996.